Structure and function of mGluR3 interactions with beta-arrestins and the membrane.
mGluR3 与 β-arrestins 和膜相互作用的结构和功能。
基本信息
- 批准号:10704588
- 负责人:
- 金额:$ 6.95万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-09-01 至 2024-08-31
- 项目状态:已结题
- 来源:
- 关键词:AffectAffinityAgonistAlanineAlzheimer&aposs DiseaseAnxietyArrestin Beta 1ArrestinsAwardBindingBiochemicalBiological AssayBiophysicsC-terminalCell physiologyCellsCellular AssayClathrinCollaborationsComplexCouplingCryoelectron MicroscopyCytoplasmDataDevelopmentDiseaseDissociationEnvironmentEventFaceFamilyFluorescenceFoundationsG Protein-Coupled Receptor SignalingG protein coupled receptor kinaseG-Protein-Coupled ReceptorsGTP-Binding ProteinsGlutamatesGoalsHeterotrimeric GTP-Binding ProteinsIn VitroInstitutionLengthLibrariesMeasurementMeasuresMediatingMembraneMembrane LipidsMembrane ProteinsMental DepressionMental disordersMentorsMetabotropic Glutamate ReceptorsMethodsMolecularMolecular ConformationMonomeric GTP-Binding ProteinsMutationNMR SpectroscopyNeuronsNeurotransmittersNucleotidesOutcomePathway interactionsPatternPhospholipidsPhosphorylationPhotobleachingPopulationProcessProtein IsoformsProteinsProtomerPublicationsRegulationReportingResearchResearch DesignResearch PersonnelResolutionSchizophreniaSerineSerine/Threonine PhosphorylationSignal PathwaySignal TransductionSiteStimulusStructureSynapsesSystemTechniquesTertiary Protein StructureThermodynamicsThreonineTrainingTransmembrane DomainVariantWorkautism spectrum disorderbeta-arrestinbiophysical techniquescareercellular imagingdesensitizationdimerexperienceextracellularhigh throughput screeningimprovedin vivo Modelinnovationmedical schoolsmeetingsmonomernervous system disordernovelpostsynapticpresynapticprogramsprotein functionreceptorreceptor functionreceptor internalizationrecruitresponsesingle moleculestoichiometry
项目摘要
PROJECT SUMMARY
This proposal contains a comprehensive program to support a transition toward an independent research career
focused on understanding how membrane protein function is modulated by interactions with other proteins and
phospholipid membranes, and how this modulation impacts cellular processes and is altered in disease-states.
This application describes an innovative and ambitious proposal directly tied to my career and training goals.
Background: G protein-coupled receptors (GPCR) are membrane proteins that sense extracelluar stimuli and
initiate intracellular signaling pathways through interactions with cytosolic G proteins. Classically, GPCRs are
thought to undergo a multi-step inactivation and desensitization process via interactions with β-arrestins following
hyper-phosphorylation of the intrinsically-disordered GPCR C-terminal domain (CTD). β-arrestins can also
initiate distinct signaling cascades in addition to desensitizing and internalizing GPCRs, though the molecular
determinants for each pathway are not well understood. This system is further complicated by the presence of
two β-arrestin isoforms which are thought to prefer different GPCR CTD phosphorylation patterns and may
initiate different cellular pathways. Metabotropic glutamate receptors (mGluR) are dimeric, neuronal GPCRs that
are responsible for sensing main excitatory neurotransmitter glutamate both pre- and post-synaptically. Recently
a single isoform, mGluR3, was identified to undergo robust β-arrestin-mediated internalization and the β-arrestin-
binding region of the CTD was identified. This was the first reported interaction between a dimeric GPCR and β-
arrestins, leading to novel questions about complex stoichiometry and structure. This mGluR3-β-arrestin
interaction is further complicated by preliminary data indicating that the β-arrestin binding region of the mGluR3
CTD also interacts with the phospholipid membrane. Specific Aims and Research Design: The proposed study
investigates the interactions between mGluR3 and both β-arrestins and the membrane using a combination of
1) single-molecule and ensemble fluorescence-based binding methods to investigate the determinants of the
formation of mGluR3-β-arrestin complexes, and 2) cryo-electron microscopy and nuclear magnetic resonance
spectroscopy to assess the structural features of interactions between mGluR3, β-arrestins, and the membrane.
My in vitro and structural findings will be validated using cellular assays and imaging. Findings will inform a
K99/R00 proposal aimed to apply the approaches and findings from this F32 research program broadly to other
GPCRs and to pursue the functional consequences of GPCR-β-arrestin coupling in in vivo models. Training
and Mentoring: Training goals are supported by 1) a team of co-sponsors Drs. Levitz and Eliezer and a close
collaborator (Dr. Meyerson) with expertise in biophysical and biochemical research, 2) a rich institutional
environment at Weill Cornell Medical College, and 3) scientific meetings, seminars, and planned publications.
Impact: The experience gained during this award will serve at the foundation for my independent career as a
protein biophysics researcher and for the development of a novel program of membrane protein research.
项目概要
该提案包含一个全面的计划,以支持向独立研究职业的过渡
专注于了解膜蛋白功能如何通过与其他蛋白质的相互作用进行调节,以及
磷脂膜,以及这种调节如何影响细胞过程并在疾病状态下发生改变。
该申请描述了一个与我的职业和培训目标直接相关的创新且雄心勃勃的提案。
背景:G蛋白偶联受体(GPCR)是感知细胞外刺激和
GPCR 通过与胞质 G 蛋白相互作用启动细胞内信号传导途径。
被认为通过与 β-arrestins 相互作用经历多步失活和脱敏过程
本质上无序的 GPCR C 末端结构域 (CTD) 的过度磷酸化也可以。
除了使 GPCR 脱敏和内化之外,还启动不同的信号级联反应,尽管分子机制
每个途径的决定因素尚不清楚。该系统因存在而变得更加复杂。
两种 β-arrestin 亚型被认为更喜欢不同的 GPCR CTD 磷酸化模式,并且可能
启动不同的细胞途径。代谢型谷氨酸受体 (mGluR) 是二聚体神经元 GPCR。
负责感知突触前和突触后的主要兴奋性神经递质谷氨酸。
单一异构体 mGluR3 被鉴定为经历强大的 β-arrestin 介导的内化,并且 β-arrestin-
CTD 的结合区域被鉴定出来,这是二聚体 GPCR 和 β- 之间首次报道的相互作用。
视紫红质抑制蛋白,引发了有关复杂化学计量和结构的新问题。
初步数据表明 mGluR3 的 β-arrestin 结合区域使相互作用进一步复杂化
CTD 还与磷脂膜相互作用。具体目标和研究设计:拟议的研究。
使用以下组合研究 mGluR3 与 β-arrestins 和膜之间的相互作用
1)基于单分子和整体荧光的结合方法来研究结合的决定因素
mGluR3-β-arrestin 复合物的形成,以及 2) 冷冻电子显微镜和核磁共振
光谱法评估 mGluR3、β-抑制蛋白和膜之间相互作用的结构特征。
我的体外和结构发现将使用细胞测定和成像进行验证,结果将为我提供信息。
K99/R00 提案旨在将该 F32 研究计划的方法和结果广泛应用于其他领域
GPCR 并在体内模型中研究 GPCR-β-arrestin 偶联的功能后果。
和指导:培训目标由 1) 共同发起人 Levitz 和 Eliezer 博士组成的团队以及密切关注的人员支持。
(Meyerson 博士)拥有生物物理和生化研究方面的专业知识,2)丰富的机构合作者
威尔康奈尔医学院的环境,以及 3) 科学会议、研讨会和计划的出版物。
影响:在这个奖项中获得的经验将为我作为独立职业者奠定基础
蛋白质生物物理学研究人员并开发了膜蛋白研究的新计划。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Dagan Marx其他文献
Dagan Marx的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Dagan Marx', 18)}}的其他基金
Structure and function of mGluR3 interactions with beta-arrestins and the membrane.
mGluR3 与 β-arrestins 和膜相互作用的结构和功能。
- 批准号:
10536255 - 财政年份:2022
- 资助金额:
$ 6.95万 - 项目类别:
相似国自然基金
抗原非特异性B细胞进入生发中心并实现亲和力成熟的潜力与调控机制
- 批准号:32370941
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
面向免疫疗法标志物识别的基于多特征融合的肽与MHC亲和力预测研究
- 批准号:62302277
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于胞内蛋白亲和力标记策略进行新型抗类风湿性关节炎的选择性OGG1小分子抑制剂的发现
- 批准号:82304698
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
DNA四面体限域辅助的高亲和力铅笔芯微电极用于早期癌症精准诊断研究
- 批准号:22304062
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于计算生物学技术小分子农兽药残留物驼源单域抗体虚拟筛选与亲和力成熟 -以内蒙古阿拉善双峰驼为例
- 批准号:32360190
- 批准年份:2023
- 资助金额:34 万元
- 项目类别:地区科学基金项目
相似海外基金
Small Molecule Degraders of Tryptophan 2,3-Dioxygenase Enzyme (TDO) as Novel Treatments for Neurodegenerative Disease
色氨酸 2,3-双加氧酶 (TDO) 的小分子降解剂作为神经退行性疾病的新疗法
- 批准号:
10752555 - 财政年份:2024
- 资助金额:
$ 6.95万 - 项目类别:
Mapping brain-wide opioid actions by profiling neuronal activities and in vivo cellular target engagement
通过分析神经元活动和体内细胞靶标参与来绘制全脑阿片类药物作用
- 批准号:
10775623 - 财政年份:2023
- 资助金额:
$ 6.95万 - 项目类别:
Partial and Controlled Depletion of SR Calcium by RyR Agonists Prevents Calcium-dependent Arrhythmias
RyR 激动剂部分且受控地消耗 SR 钙可预防钙依赖性心律失常
- 批准号:
10577630 - 财政年份:2023
- 资助金额:
$ 6.95万 - 项目类别:
Protease-activated-receptor-2 antagonists for treatment of migraine pain
蛋白酶激活受体 2 拮抗剂治疗偏头痛
- 批准号:
10602826 - 财政年份:2023
- 资助金额:
$ 6.95万 - 项目类别:
Rational Design from Cryo-EM Structures of High-Affinity Ryanodine Receptor Ligands Based on Natural Peptides
基于天然肽的高亲和力兰尼定受体配体的冷冻电镜结构的合理设计
- 批准号:
10729564 - 财政年份:2023
- 资助金额:
$ 6.95万 - 项目类别: